Journals / Epilepsi / 2016 / Cilt: 22 - Sayı: 2

Action Myoclonus and Renal Parenchymal Disease: A Case Report

Aksiyon Miyoklonusu ve Renal Parankimal Hastalık Birlikteliği: Olgu sunumu

Journal
Epilepsi
Pages
67–71
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient died at 25 years of age in a context of end-stage renal function consistent with nephrotic syndrome

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Progressive myoclonic epilepsies are a devastating group of rare disorders.
📊
Key Findings & Data:The case of a young man who presented with a late-diagnosed nephrotic syndrome, progressive myoclonic seizures with action myoclonus, is described in the present report.
💡
Conclusion & Impact:The patient died at 25 years of age in a context of end-stage renal function consistent with nephrotic syndrome
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Progressive myoclonic epilepsies are a devastating group of rare disorders. The case of a young man who presented with a late-diagnosed nephrotic syndrome, progressive myoclonic seizures with action myoclonus, is described in the present report. He was the fifth child of a consanguineous marriage, and there was no familial history of nephrotic syndrome or end-stage renal failure. Renal biopsy showed focal segmental glomerulosclerosis with collapsing glomerulopathy. The patient died at 25 years of age in a context of end-stage renal function consistent with nephrotic syndrome

Özet

Progresif miyoklonik epilepsiler, kötü prognozlu nadir hastalıklarıdan biridir. Bu yazıda, aksiyon miyoklonusu olan progresif myloklonik epilepsili ve geç yaşta nefrotik sendrom tanısı almış genç bir hasta tanımlandı. Hasta akraba evliliğinden doğan ailenin beşinci çocuğuydu. Ailede nefrotik sendrom ya da böbrek yetersizliği tanılı bir yakını yoktu. Renal ince iğne biyopsisi kollabe glomerülopatinin olduğu fokal segmental glomerüloskleroz ile sonuçlandı. Hasta 25 yaşında nefrotik sendroma sekonder son evre böbrek yetersizliği sonrası yaşamını yitirdi.

🔖

Cite This Article

ASLAN, K., ERDEM, M., BAĞIR, E. K., GÖNLÜŞEN, G., BOZDEMİR, H. (2016). Action Myoclonus and Renal Parenchymal Disease: A Case Report. Epilepsi, Cilt: 22 - Sayı: 2, 67–71. https://ajindex.com/articles/160711

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Andermann E, Andermann F, Carpenter S, Wolfe LS, Nelson R, Patry G, et al. Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology. Adv Neurol 1986;43:87–103.
  2. Badhwar A, Berkovic SF, Dowling JP, Gonzales M, Narayanan S, Brodtmann A, et al. Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder. Brain 2004;127(Pt 10):2173–82.
  3. Vadlamudi L, Vears DF, Hughes A, Pedagogus E, Berkovic SF. Action myoclonus-renal failure syndrome: a cause for worsening tremor in young adults. Neurology 2006;67(7):1310–1.
  4. Dibbens LM, Michelucci R, Gambardella A, Andermann F, Rubboli G, Bayly MA, et al. SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Ann Neurol 2009;66(4):532–6.
  5. Chaves J, Beirão I, Balreira A, Gaspar P, Caiola D, Sá-Miranda MC, et al. Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: clinical report of two siblings. Seizure 2011;20(9):738–40.
  6. Rubboli G, Franceschetti S, Berkovic SF, Canafoglia L, Gambardella A, Dibbens LM, et al. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations. Epilepsia 2011;52(12):2356–63.
  7. Balreira A, Gaspar P, Caiola D, Chaves J, Beirão I, Lima JL, et al. A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome. Hum Mol Genet 2008;17(14):2238–43.
  8. Gaspar P, Kallemeijn WW, Strijland A, Scheij S, Van Eijk M, Aten J, et al. Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. J Lipid Res 2014;55(1):138–45.
  9. Balreira A, Gaspar P, Caiola D, Chaves J, Beirão I, Lima JL, et al. A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome. Hum Mol Genet 2008;17(14):2238–43.